253 related articles for article (PubMed ID: 30925862)
21. PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy.
Bian X; Gao J; Luo F; Rui C; Zheng T; Wang D; Wang Y; Roberts TM; Liu P; Zhao JJ; Cheng H
Oncogene; 2018 Jan; 37(3):341-351. PubMed ID: 28945226
[TBL] [Abstract][Full Text] [Related]
22. Heat shock protein 90 (HSP90) is overexpressed in p16-negative oropharyngeal squamous cell carcinoma, and its inhibition in vitro potentiates the effects of chemoradiation.
Patel K; Wen J; Magliocca K; Muller S; Liu Y; Chen ZG; Saba N; Diaz R
Cancer Chemother Pharmacol; 2014 Nov; 74(5):1015-22. PubMed ID: 25205430
[TBL] [Abstract][Full Text] [Related]
23. shRNA-mediated inhibition of PhosphoGlycerate Kinase 1 (PGK1) enhances cytotoxicity of intraperitoneal chemotherapy in peritoneal metastasis of gastric origin.
Archid R; Zieker D; Weinreich FJ; Hönes F; Königsrainer A; Quintanilla-Martínez L; Reymond MA; Solass W
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):613-619. PubMed ID: 31980221
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
[TBL] [Abstract][Full Text] [Related]
25. [Expression of phosphoglycerate kinase 1 in endometrial carcinoma and its association with patients' outcome].
Lin L; Jiang QP; Lin D; Chen W; Jiang HP; Liu CH; Xiao YY; Zhu LT; Guo SQ
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):471-476. PubMed ID: 29735450
[TBL] [Abstract][Full Text] [Related]
26. siPGK1 sensitizes chemoresistant human ovarian cancer cell lines to cisplatin.
Lepleux C; Abeilard-Lemoisson E; Duval M; Icard P; Lincet H
Anticancer Res; 2012 Oct; 32(10):4277-86. PubMed ID: 23060548
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells.
Ohba S; Hirose Y; Yoshida K; Yazaki T; Kawase T
J Neurosurg; 2010 Jan; 112(1):33-42. PubMed ID: 19408974
[TBL] [Abstract][Full Text] [Related]
28. Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor.
Nishimura T; Nakamura K; Yamashita S; Ikeda S; Kigure K; Minegishi T
BMC Cancer; 2015 Dec; 15():957. PubMed ID: 26673416
[TBL] [Abstract][Full Text] [Related]
29. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
Ribeiro JR; Schorl C; Yano N; Romano N; Kim KK; Singh RK; Moore RG
J Ovarian Res; 2016 May; 9(1):28. PubMed ID: 27184254
[TBL] [Abstract][Full Text] [Related]
30. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
[TBL] [Abstract][Full Text] [Related]
31. Correlation between the DNA global methylation status and progesterone receptor expression in normal endometrium, endometrioid adenocarcinoma and precursors.
Ghabreau L; Roux JP; Niveleau A; Fontanière B; Mahe C; Mokni M; Frappart L
Virchows Arch; 2004 Aug; 445(2):129-34. PubMed ID: 15221375
[TBL] [Abstract][Full Text] [Related]
32. Expression of type 2 orexin receptor in human endometrium and its epigenetic silencing in endometrial cancer.
Dehan P; Canon C; Trooskens G; Rehli M; Munaut C; Van Criekinge W; Delvenne P
J Clin Endocrinol Metab; 2013 Apr; 98(4):1549-57. PubMed ID: 23482607
[TBL] [Abstract][Full Text] [Related]
33. CNR1 may reverse progesterone-resistance of endometrial cancer through the ERK pathway.
Ding F; Qiu C; Li W; Liu Z; Kong D; Ma X; Jiang J
Biochem Biophys Res Commun; 2021 Apr; 548():148-154. PubMed ID: 33640608
[TBL] [Abstract][Full Text] [Related]
34. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
Kashima H; Wu RC; Wang Y; Sinno AK; Miyamoto T; Shiozawa T; Wang TL; Fader AN; Shih IeM
Gynecol Oncol; 2015 Nov; 139(2):338-44. PubMed ID: 26343160
[TBL] [Abstract][Full Text] [Related]
35. KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance.
Xu W; Zhou B; Zhao X; Zhu L; Xu J; Jiang Z; Chen D; Wei Q; Han M; Feng L; Wang S; Wang X; Zhou J; Jin H
Int J Biol Sci; 2018; 14(9):1122-1132. PubMed ID: 29989047
[TBL] [Abstract][Full Text] [Related]
36. Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.
Goto T; Takano M; Albergaria A; Briese J; Pomeranz KM; Cloke B; Fusi L; Feroze-Zaidi F; Maywald N; Sajin M; Dina RE; Ishihara O; Takeda S; Lam EW; Bamberger AM; Ghaem-Maghami S; Brosens JJ
Oncogene; 2008 Jan; 27(1):9-19. PubMed ID: 17599040
[TBL] [Abstract][Full Text] [Related]
37. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
[TBL] [Abstract][Full Text] [Related]
38. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
[TBL] [Abstract][Full Text] [Related]
39. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
[TBL] [Abstract][Full Text] [Related]
40. T-Box Transcription Factor 2 Enhances Chemoresistance of Endometrial Cancer by Mediating NRF2 Expression.
Ding N; Zhang T; Yu X; Zhuang S
Curr Protein Pept Sci; 2022; 23(8):563-570. PubMed ID: 36017860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
